Skip to main content

Table 2 Healthcare utilization among individuals with AS by age

From: An observational study of pediatric healthcare burden in Angelman syndrome: results from a real-world study

Descriptive

0–1

2

3

4

5

6

7

8

9

10

11

12

N1

301

282

260

234

208

179

155

134

114

92

77

65

Hospitalization summary measures

 Had hospitalization, %

43

24

21

18

14

13

13

10

12

7

8

11

 Hospitalization per year, mean

1.5

1.3

1.3

1.6

1.4

1.1

1.1

1.2

1.4

1.2

1.3

1.1

 LOS, mean

6.5

3.1

2.5

2.6

4.7

3.6

3.1

2.7

2.9

1

3.4

1.5

Most common reasons for hospitalization

 Seizures, %

10

11

10

6

7

5

5

4

3

0

3

1

 Lower respiratory infection, %

10

5

1

3

1

1

1

2

3

1

0

0

 Surgery, %

5

3

2

2

1

0

1

2

0

0

0

0

Surgery summary measure

 Had surgery, %

29

21

15

17

9

9

14

8

9

4

8

5

Most common reasons for surgery

 Tympanostomy tubes, %

10

5

5

3

4

1

2

0

2

0

1

0

 Strabismus, %

7

9

2

3

1

2

2

1

1

0

0

0

 Tonsillectomy & adenoidectomy, %

2

2

5

5

2

2

1

0

1

0

0

0

Medication summary measures

 Number of prescription medications, mean

2.1

2.0

2.1

2.3

2.3

2.1

2.2

2.2

2.3

2.5

2.5

2.7

 At least one prescription medication, %

51

59

69

71

76

78

81

81

83

77

78

77

  Anti-epileptic drugs, %

32

50

61

64

67

69

73

71

72

71

70

69

  Anti-gastroesophageal reflux medication, %

27

15

12

13

12

13

11

12

13

10

12

9

  Asthma and Allergy medication, %

5

5

7

9

7

6

7

7

8

5

4

6

  Antibiotic, %

3

1

4

2

1

1

2

1

1

2

0

2

  Sleep medication, %

3

6

9

12

15

18

17

19

18

16

20

26

  Psychotropic medication, %

1

1

2

6

9

9

13

15

17

22

20

23

  Other, %

2

1

6

5

6

5

8

6

5

7

10

11

 Number of non-prescription medications, mean

1.6

1.9

1.8

1.9

1.9

2.0

2.0

2.1

2.1

2.2

2.1

1.8

  Asthma and Allergy, %

3

5

5

6

7

7

8

5

5

5

7

8

  Laxative, %

11

14

15

15

14

14

18

19

17

19

16

19

  Sleep medication, %

18

30

31

35

37

33

33

34

31

29

25

23

  1. Notes: 1Age is rounded down to the nearest year. The event counts for each age are based on the participants reported age at a specific event. Participant are included in the overall N (denominator) for each age group until their age at last visit (the oldest age recorded). Participants are only counted once per age. For ages 0–1 Year, the sum of the number of unique prescription/non-prescription medications taken at age 0 and at age 1 is summarized